Cover Image
Market Research Report
Product code
1018665

Global Multiplex Assay Market Forecast 2021-2028

Published: | Inkwood Research | 240 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Multiplex Assay Market Forecast 2021-2028
Published: July 19, 2021
Inkwood Research
Content info: 240 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The global multiplex assay market is forecasted to register a CAGR of 8.74% over the estimated period of 2021 to 2028. The market growth is facilitated by key factors like increased government funding as well as research and development activities, the growing preference of multiplex assays over conventional assays, and the growing adoption of personalized medicines.

MARKET INSIGHTS

A multiplex assay is a procedure in which several analytes, including proteins, cytokines, biomolecules, growth factors, chemokines, and others are profiled by detecting and quantifying them simultaneously. The assay is utilized to amplify multiple targets in a polymerase chain reaction (PCR) and gather added information from minute quantities of proteins or other analytes in lesser time compared to traditional methods like ELISA.

Multiplex assays hold tremendous potential in the research and development of drugs for the treatment of diseases, such as cancer and cardiovascular diseases. For instance, bead-based Luminex xMAP multiplex assay offers a platform for cancer biomarker assays compatible with plasma, cultured cells, serum, as well as other biological samples. The American Association of Cancer Research (AACR) designed the multiplex immunoassay that assisted in the examination of acquired resistance to receptor tyrosine kinase (RTK) inhibitors. Moreover, RTK is utilized as a target for drug development to treat cancer.

REGIONAL INSIGHTS

The global multiplex assay market growth assessment includes the analysis of North America, Europe, the Asia-Pacific, and the Rest of World. North America is set to harbor the highest market share by the end of the forecast period. The market growth is attributed to key drivers such as the increasing research and development activities of new drugs as well as treatment options, the rise in government funds for detecting new biomarkers, and the growing incidence of chronic conditions like stroke and cancer.

COMPETITIVE INSIGHTS

The intensity of competitive rivalry within the global multiplex assay market is anticipated to remain high over the projected years. Companies in the market adopt several strategies, including new product developments, mergers and acquisitions, and collaborations in order to compete and retain their market share. The trend continues to remain the same due to the entrance of new firms as well as the rising adoption of multiplex assay technology, anticipated to generate new opportunities in the global market.

Some of the leading firms operating in the market include: F. Hoffmann-la Roche, Agilent Technologies Inc, Qiagen NV, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 28500

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. GOVERNMENTAL FUNDING AND R&D ACTIVITIES
    • 3.1.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
    • 3.1.3. ADOPTION OF PERSONALIZED MEDICINES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. UNAVAILABILITY OF SKILLED LAB TECHNICIANS
    • 3.2.2. COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATIONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. KEY BUYING CRITERIA
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE

5. MARKET BY TYPE

  • 5.1. PROTEIN-BASED MULTIPLEX ASSAY
  • 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
  • 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

  • 6.1. REAGENTS AND CONSUMABLES
  • 6.2. INSTRUMENTS AND ACCESSORIES
  • 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

  • 7.1. MULTIPLEX PROTEIN MICROARRAY
  • 7.2. MULTIPLEX PCR
  • 7.3. OTHER TECHNOLOGIES

8. MARKET BY APPLICATION

  • 8.1. CLINICAL DIAGNOSTICS
  • 8.2. RESEARCH AND DEVELOPMENT
  • 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

  • 9.1. HOSPITALS
  • 9.2. CLINICAL LABORATORIES
  • 9.3. RESEARCH INSTITUTES
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. MARKET SIZE & ESTIMATES
    • 10.2.2. KEY GROWTH ENABLERS
    • 10.2.3. KEY CHALLENGES
    • 10.2.4. KEY PLAYERS
    • 10.2.5. COUNTRY ANALYSIS
      • 10.2.5.1. GERMANY
      • 10.2.5.2. FRANCE
      • 10.2.5.3. UNITED KINGDOM
      • 10.2.5.4. ITALY
      • 10.2.5.5. RUSSIA
      • 10.2.5.6. BELGIUM
      • 10.2.5.7. POLAND
      • 10.2.5.8. REST OF EUROPE
  • 10.3. ASIA-PACIFIC
    • 10.3.1. MARKET SIZE & ESTIMATES
    • 10.3.2. KEY GROWTH ENABLERS
    • 10.3.3. KEY CHALLENGES
    • 10.3.4. KEY PLAYERS
    • 10.3.5. COUNTRY ANALYSIS
      • 10.3.5.1. CHINA
      • 10.3.5.2. JAPAN
      • 10.3.5.3. INDIA
      • 10.3.5.4. AUSTRALIA & NEW ZEALAND
      • 10.3.5.5. SOUTH KOREA
      • 10.3.5.6. THAILAND
      • 10.3.5.7. INDONESIA
      • 10.3.5.8. VIETNAM
      • 10.3.5.9. REST OF ASIA-PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. MARKET SIZE & ESTIMATES
    • 10.4.2. KEY GROWTH ENABLERS
    • 10.4.3. KEY CHALLENGES
    • 10.4.4. KEY PLAYERS
    • 10.4.5. REGIONAL ANALYSIS
      • 10.4.5.1. LATIN AMERICA
      • 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGERS & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 11.1.3. PARTNERSHIPS & AGREEMENTS
    • 11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
  • 11.2. COMPANY PROFILES
    • 11.2.1. ABCAM
    • 11.2.2. AGILENT TECHNOLOGIES INC
    • 11.2.3. BECTON, DICKINSON AND COMPANY (BD)
    • 11.2.4. BIO-RAD LABORATORIES INC
    • 11.2.5. BIO-TECHNE CORPORATION
    • 11.2.6. F. HOFFMANN-LA ROCHE
    • 11.2.7. ILLUMINA INC
    • 11.2.8. LUMINEX CORPORATION
    • 11.2.9. MERCK MILLIPORE
    • 11.2.10. OLINK PROTEOMICS AB
    • 11.2.11. QIAGEN NV
    • 11.2.12. RANDOX LABORATORIES LTD
    • 11.2.13. SEEGENE INC
    • 11.2.14. SIEMENS HEALTHINEERS AG
    • 11.2.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - MULTIPLEX ASSAY
  • TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL MULTIPLEX PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL MULTIPLEX PCR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: LEADING PLAYERS OPERATING IN THE NORTH AMERICA MULTIPLEX ASSAY MARKET
  • TABLE 49: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 50: EUROPE MULTIPLEX ASSAY, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 51: LEADING PLAYERS OPERATING IN EUROPE MULTIPLEX ASSAY MARKET
  • TABLE 52: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 53: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET
  • TABLE 55: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 56: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 57: LEADING PLAYERS OPERATING IN REST OF WORLD MULTIPLEX ASSAY MARKET
  • TABLE 58: LIST OF MERGERS & ACQUISITIONS
  • TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 61: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
  • FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
  • FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
  • FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
  • FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
  • FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 28: UNITED STATES MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: CANADA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 31: GERMANY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: FRANCE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: ITALY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: RUSSIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: BELGIUM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: POLAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 40: CHINA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: JAPAN MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: INDIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: THAILAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: INDONESIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: VIETNAM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: REST OF WORLD MULTIPLEX ASSAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 50: LATIN AMERICA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)